Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kufner

Showing results (331-340 of 370) with videos related to

Pageof 37
Sort By:
European Heart Journal|October 30, 2024
Comparison of strategies for vascular ACCESS closure after Transcatheter Aortic Valve Implantation: the ACCESS-TAVI randomized trialTobias Rheude, Hendrik Ruge, Niklas Altaner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 25, 2025
Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosisJ Krefting, N Krüger, C Friess, et al.
International Journal of Cardiology|June 14, 2021
Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromesShqipdona Lahu, Gjin Ndrepepa, Senta Gewalt, et al.
Circulation. Cardiovascular Interventions|June 16, 2021
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary InterventionJ J Coughlan, Alp Aytekin, Gjin Ndrepepa, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2014
Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trialErion Xhepa, Robert A Byrne, Stefanie Schulz, et al.
Thrombosis and Haemostasis|November 28, 2022
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesTobias Koch, Shqipdona Lahu, J J Coughlan, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 22, 2022
Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes-a subgroup analysis of the ISAR-REACT 5 trialShqipdona Lahu, Gjin Ndrepepa, Franz-Josef Neumann, et al.
Wiener Klinische Wochenschrift|November 14, 2014
HerzMobil Tirol network: rationale for and design of a collaborative heart failure disease management program in AustriaAndreas Von der Heidt, Elske Ammenwerth, Karl Bauer, et al.
The Journal of Clinical Investigation|April 28, 2022
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody responseMaddalena Marconato, Irene A Abela, Anthony Hauser, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 7, 2020
Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosisErion Xhepa, Jola Bresha, Michael Joner, et al.
Pageof 37

Showing results (331-340 of 370) with videos related to

Sort By:
Pageof 37
European Heart Journal|October 30, 2024
Comparison of strategies for vascular ACCESS closure after Transcatheter Aortic Valve Implantation: the ACCESS-TAVI randomized trialTobias Rheude, Hendrik Ruge, Niklas Altaner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 25, 2025
Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosisJ Krefting, N Krüger, C Friess, et al.
International Journal of Cardiology|June 14, 2021
Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromesShqipdona Lahu, Gjin Ndrepepa, Senta Gewalt, et al.
Circulation. Cardiovascular Interventions|June 16, 2021
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary InterventionJ J Coughlan, Alp Aytekin, Gjin Ndrepepa, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2014
Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trialErion Xhepa, Robert A Byrne, Stefanie Schulz, et al.
Thrombosis and Haemostasis|November 28, 2022
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesTobias Koch, Shqipdona Lahu, J J Coughlan, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 22, 2022
Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes-a subgroup analysis of the ISAR-REACT 5 trialShqipdona Lahu, Gjin Ndrepepa, Franz-Josef Neumann, et al.
Wiener Klinische Wochenschrift|November 14, 2014
HerzMobil Tirol network: rationale for and design of a collaborative heart failure disease management program in AustriaAndreas Von der Heidt, Elske Ammenwerth, Karl Bauer, et al.
The Journal of Clinical Investigation|April 28, 2022
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody responseMaddalena Marconato, Irene A Abela, Anthony Hauser, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 7, 2020
Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosisErion Xhepa, Jola Bresha, Michael Joner, et al.
Pageof 37